PURIBLOOD MEDICAL CO., LTDMarch 14, 2025

FDA 483 - PURIBLOOD MEDICAL CO., LTD - March 14, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PURIBLOOD MEDICAL CO., LTD

Record Details

An FDA inspection of PURIBLOOD MEDICAL CO., LTD in Baoshan Township, Taiwan, revealed significant deficiencies in the firm's quality system. Observations included inadequate procedures for corrective and preventive actions, particularly regarding root cause analysis and effectiveness verification. Additionally, the firm failed to adequately establish procedures for complaint handling and ensuring purchased products and services conform to specified requirements.

Company: PURIBLOOD MEDICAL CO., LTD
Inspection Date: March 14, 2025
Product Type: Device
Office: Division of Blood Components and Devices
People: Creighton T. Tuzon
Nisha C. Patel

Open in Dashboard

ID · e6923826-20b0-44d0-81f8-c9aa309dd263